{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:53:40Z","timestamp":1793642020368,"version":"4.5.1"},"reference-count":238,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bcp.2023.115923","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T04:39:46Z","timestamp":1700282386000},"page":"115923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseases"],"prefix":"10.1016","volume":"218","author":[{"given":"Chengfeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8193-7561","authenticated-orcid":false,"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2023.115923_b0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.semcancer.2017.12.010","article-title":"Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer","volume":"56","author":"Nagini","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcp.2023.115923_b0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0076-6879(83)99069-9","article-title":"Glycogen synthase kinase-3 from rabbit skeletal muscle","volume":"99","author":"Hemmings","year":"1983","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1432-1033.1982.tb05902.x","article-title":"Separation and characterisation of glycogen synthase kinase 3, glycogen synthase kinase 4 and glycogen synthase kinase 5 from rabbit skeletal muscle","volume":"124","author":"Cohen","year":"1982","journal-title":"Eur. J. Biochem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115923_b0020","doi-asserted-by":"crossref","first-page":"e105513","DOI":"10.15252\/embj.2020105513","article-title":"GSK3alpha, not GSK3beta, drives hippocampal NMDAR-dependent LTD via tau-mediated spine anchoring","volume":"40","author":"Draffin","year":"2021","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.bcp.2023.115923_b0025","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/j.1460-2075.1990.tb07419.x","article-title":"Molecular cloning and expression of glycogen synthase kinase-3\/factor A","volume":"9","author":"Woodgett","year":"1990","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b0030","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI64398","article-title":"GSK-3alpha is a central regulator of age-related pathologies in mice","volume":"123","author":"Zhou","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2023.115923_b0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnmol.2011.00040","article-title":"GSK-3: Functional Insights from Cell Biology and Animal Models","volume":"4","author":"Kaidanovich-Beilin","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2023.115923_b0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cytogfr.2020.08.002","article-title":"Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic","volume":"58","author":"Rana","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bcp.2023.115923_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101787","article-title":"AChE as a spark in the Alzheimer's blaze - Antagonizing effect of a cyclized variant","volume":"83","author":"Behl","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"27","key":"10.1016\/j.bcp.2023.115923_b0050","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.2174\/0929867329666220216113517","article-title":"Glycogen synthase kinase 3beta involvement in neuroinflammation and neurodegenerative diseases","volume":"29","author":"Gianferrara","year":"2022","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2023.115923_b0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem. J"},{"key":"10.1016\/j.bcp.2023.115923_b0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2023.115923_b0065","first-page":"1869","article-title":"GSK-3 at the heart of cardiometabolic diseases: Isoform-specific targeting is critical to therapeutic benefit","volume":"6","author":"Umbarkar","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bcp.2023.115923_b0070","doi-asserted-by":"crossref","unstructured":"Wagner, F. F.; Benajiba, L.; Campbell, A. J.; Weiwer, M.; Sacher, J. R.; Gale, J. P.; Ross, L.; Puissant, A.; Alexe, G.; Conway, A.; Back, M.; Pikman, Y.; Galinsky, I.; DeAngelo, D. J.; Stone, R. M.; Kaya, T.; Shi, X.; Robers, M. B.; Machleidt, T.; Wilkinson, J.; Hermine, O.; Kung, A.; Stein, A. J.; Lakshminarasimhan, D.; Hemann, M. T.; Scolnick, E.; Zhang, Y. L.; Pan, J. Q.; Stegmaier, K.; Holson, E. B., Exploiting an Asp-Glu \u201cswitch\u201d in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia. Sci. Transl. Med. 10 (2018) 431.","DOI":"10.1126\/scitranslmed.aam8460"},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1471-4159.2010.06581.x","article-title":"The neuron-specific isoform of glycogen synthase kinase-3beta is required for axon growth","volume":"113","author":"Castano","year":"2010","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.bcp.2023.115923_b0080","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/emboj\/cdg068","article-title":"Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex","volume":"22","author":"Dajani","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2023.115923_b0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ijms24087541","article-title":"GSK-3beta Allosteric Inhibition: A Dead End or a New Pharmacological Frontier?","volume":"24","author":"Balboni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2023.115923_b0090","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1096\/fasebj.9.8.7768349","article-title":"Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification","volume":"9","author":"Hanks","year":"1995","journal-title":"FASEB J."},{"issue":"22","key":"10.1016\/j.bcp.2023.115923_b0095","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1073\/pnas.220413597","article-title":"Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A","volume":"97","author":"Fang","year":"2000","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bcp.2023.115923_b0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/abbs\/gmz156","article-title":"Glycogen synthase kinase-3 as a key regulator of cognitive function","volume":"52","author":"Fan","year":"2020","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.bcp.2023.115923_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110391","article-title":"Many faces and functions of GSKIP: a temporospatial regulation view","volume":"97","author":"Wu","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2023.115923_b0110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-cellbio-120319-023657","article-title":"Cell Biology of Canonical Wnt Signaling","volume":"37","author":"Albrecht","year":"2021","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2009.09.007","article-title":"Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)","volume":"31","author":"Beurel","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bcp.2023.115923_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105082","article-title":"Dimethyl fumarate abridged tauo-\/amyloidopathy in a D-Galactose\/ovariectomy-induced Alzheimer's-like disease: Modulation of AMPK\/SIRT-1, AKT\/CREB\/BDNF, AKT\/GSK-3beta, adiponectin\/Adipo1R, and NF-kappaB\/IL-1beta\/ROS trajectories","volume":"148","author":"Abd El-Fatah","year":"2021","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.bcp.2023.115923_b0125","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S1097-2765(01)00253-2","article-title":"A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation","volume":"7","author":"Frame","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2023.115923_b0130","doi-asserted-by":"crossref","first-page":"e02663","DOI":"10.7554\/eLife.02663","article-title":"GSK-3 signaling in developing cortical neurons is essential for radial migration and dendritic orientation","volume":"3","author":"Morgan-Smith","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2023.115923_b0135","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.neuron.2006.10.031","article-title":"Essential Roles for GSK-3s and GSK-3-Primed Substrates in Neurotrophin-Induced and Hippocampal Axon Growth","volume":"52","author":"Kim","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2023.115923_b0140","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1007\/s12035-015-9326-8","article-title":"Loss of GSK-3 Causes Abnormal Astrogenesis and Behavior in Mice","volume":"53","author":"Jung","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"6791","key":"10.1016\/j.bcp.2023.115923_b0145","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35017574","article-title":"Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation","volume":"406","author":"Hoeflich","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2023.115923_b0150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2007.08.013","article-title":"Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism","volume":"6","author":"MacAulay","year":"2007","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b0155","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1471-4159.2010.06988.x","article-title":"Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain","volume":"115","author":"Soutar","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2023.115923_b0160","doi-asserted-by":"crossref","first-page":"(2)","DOI":"10.3390\/cells10020262","article-title":"Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration","volume":"10","author":"Rippin","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2023.115923_b0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0891-0618(02)00014-5","article-title":"Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain","volume":"23","author":"Yao","year":"2002","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.bcp.2023.115923_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6606-2-35","article-title":"Abnormalities in brain structure and behavior in GSK-3alpha mutant mice","volume":"2","author":"Kaidanovich-Beilin","year":"2009","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bcp.2023.115923_b0175","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1098\/rstb.2012.0094","article-title":"Selective deletion of forebrain glycogen synthase kinase 3beta reveals a central role in serotonin-sensitive anxiety and social behaviour","volume":"367","author":"Latapy","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.bcp.2023.115923_b0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000382029","article-title":"GSK-3beta inhibition affects singing behavior and neurogenesis in adult songbirds","volume":"85","author":"Aloni","year":"2015","journal-title":"Brain Behav. Evol."},{"key":"10.1016\/j.bcp.2023.115923_b0185","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.febslet.2011.03.025","article-title":"Selective loss of glycogen synthase kinase-3alpha in birds reveals distinct roles for GSK-3 isozymes in tau phosphorylation","volume":"585","author":"Alon","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2023.115923_b0190","doi-asserted-by":"crossref","first-page":"eaam8460","DOI":"10.1126\/scitranslmed.aam8460","article-title":"Exploiting an Asp-Glu \u201cswitch\u201d in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia","volume":"10","author":"Wagner","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2023.115923_b0195","doi-asserted-by":"crossref","first-page":"eaam8572","DOI":"10.1126\/scitranslmed.aam8572","article-title":"Selective inhibition of glycogen synthase kinase 3alpha corrects pathophysiology in a mouse model of fragile X syndrome","volume":"12","author":"McCamphill","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2023.115923_b0200","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0306-4522(02)00236-1","article-title":"Neonatal neuronal overexpression of glycogen synthase kinase-3 beta reduces brain size in transgenic mice","volume":"113","author":"Spittaels","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2023.115923_b0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","article-title":"Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice","volume":"20","author":"Lucas","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2023.115923_b0210","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1523\/JNEUROSCI.4753-03.2004","article-title":"Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium","volume":"24","author":"O\u2019Brien","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2023.115923_b0215","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/FBP.0b013e3282feb099","article-title":"Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: Negative results","volume":"19","author":"Bersudsky","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115923_b0220","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1038\/s41386-020-00819-0","article-title":"GSK3beta inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia","volume":"45","author":"Nakao","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2023.115923_b0225","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/sj.emboj.7600633","article-title":"Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis","volume":"24","author":"McManus","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2023.115923_b0230","doi-asserted-by":"crossref","first-page":"(4)","DOI":"10.3390\/ijms22042206","article-title":"Macrophage Function and the Role of GSK3","volume":"22","author":"Patel","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 7","key":"10.1016\/j.bcp.2023.115923_b0235","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J. Cell Sci."},{"issue":"8","key":"10.1016\/j.bcp.2023.115923_b0240","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","article-title":"Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation","volume":"22","author":"Liu","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2023.115923_b0245","first-page":"S141","article-title":"GSK3 and tau: two convergence points in Alzheimer's disease","volume":"33","author":"Hernandez","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bcp.2023.115923_b0250","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41419-021-04440-x","article-title":"HMGA1 stimulates MYH9-dependent ubiquitination of GSK-3\u03b2 via PI3K\/Akt\/c-Jun signaling to promote malignant progression and chemoresistance in gliomas","volume":"12","author":"Que","year":"2021","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.bcp.2023.115923_b0255","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/CIRCRESAHA.118.312789","article-title":"Protein S-Nitrosylation Controls Glycogen Synthase Kinase 3beta Function Independent of Its Phosphorylation State","volume":"122","author":"Wang","year":"2018","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bcp.2023.115923_b0260","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1042\/BCJ20210829","article-title":"N-terminal phosphorylation regulates the activity of glycogen synthase kinase 3 from Plasmodium falciparum","volume":"479","author":"Pazicky","year":"2022","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2023.115923_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101855","article-title":"Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases","volume":"86","author":"Gupta","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"12","key":"10.1016\/j.bcp.2023.115923_b0270","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/jat.4179","article-title":"Cadmium inhibits neural stem\/progenitor cells proliferation via MitoROS-dependent AKT\/GSK-3beta\/beta-catenin signaling pathway","volume":"41","author":"Luo","year":"2021","journal-title":"J. Appl. Toxicol."},{"issue":"6480","key":"10.1016\/j.bcp.2023.115923_b0275","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/369486a0","article-title":"Involvement of a calcineurin\/inhibitor-1 phosphatase cascade in hippocampal long-term depression","volume":"369","author":"Mulkey","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2023.115923_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112620","article-title":"Effect of Lycium barbarum polysaccharides on cell signal transduction pathways","volume":"147","author":"Qi","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.bcp.2023.115923_b0285","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/15548627.2022.2062112","article-title":"Acetylation in the regulation of autophagy","volume":"19","author":"Xu","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.bcp.2023.115923_b0290","doi-asserted-by":"crossref","unstructured":"Sarikhani, M.; Mishra, S.; Maity, S.; Kotyada, C.; Wolfgeher, D.; Gupta, M. P.; Singh, M.; Sundaresan, N. R., SIRT2 deacetylase regulates the activity of GSK3 isoforms independent of inhibitory phosphorylation. eLife 7 (2018).","DOI":"10.7554\/eLife.32952"},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0295","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/MCB.00586-15","article-title":"SIRT3 blocks aging-associated tissue fibrosis in mice by deacetylating and activating glycogen synthase kinase 3beta","volume":"36","author":"Sundaresan","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2023.115923_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100835","article-title":"PAD4-dependent citrullination of nuclear translocation of GSK3beta promotes colorectal cancer progression via the degradation of nuclear CDKN1A","volume":"33","author":"Luo","year":"2022","journal-title":"Neoplasia"},{"issue":"29","key":"10.1016\/j.bcp.2023.115923_b0305","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1073\/pnas.1308362110","article-title":"Dysregulation of PAD4-mediated citrullination of nuclear GSK3beta activates TGF-beta signaling and induces epithelial-to-mesenchymal transition in breast cancer cells","volume":"110","author":"Stadler","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2023.115923_b0310","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1874091X00802010067","article-title":"Regulation of glycogen synthase kinase 3beta functions by modification of the small ubiquitin-like modifier","volume":"2","author":"Eun Jeoung","year":"2008","journal-title":"Open Biochem. J."},{"key":"10.1016\/j.bcp.2023.115923_b0315","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1478-811X-11-5","article-title":"ARTD10 substrate identification on protein microarrays: Regulation of GSK3\u03b2 by mono-ADP-ribosylation","volume":"11","author":"Feijs","year":"2013","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2023.115923_b0320","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nsmb.2521","article-title":"Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases","volume":"20","author":"Rosenthal","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"31","key":"10.1016\/j.bcp.2023.115923_b0325","doi-asserted-by":"crossref","first-page":"22406","DOI":"10.1074\/jbc.M702793200","article-title":"N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation","volume":"282","author":"Goni-Oliver","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115923_b0330","doi-asserted-by":"crossref","first-page":"22521","DOI":"10.1074\/jbc.M111.321349","article-title":"Site-specific phosphorylation protects glycogen synthase kinase-3beta from calpain-mediated truncation of its N and C termini","volume":"287","author":"Ma","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b0335","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/cvr\/cvp175","article-title":"Glycogen synthase kinase-3beta is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts","volume":"83","author":"Kandasamy","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.bcp.2023.115923_b0340","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41375-021-01243-z","article-title":"GSK-3: a multifaceted player in acute leukemias","volume":"35","author":"Martelli","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2023.115923_b0345","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-030-94004-1_9","article-title":"Wnt, GSK3, and Macropinocytosis","volume":"98","author":"Tejeda-Munoz","year":"2022","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bcp.2023.115923_b0350","doi-asserted-by":"crossref","first-page":"e1007178","DOI":"10.1371\/journal.pgen.1007178","article-title":"Axin phosphorylation in both Wnt-off and Wnt-on states requires the tumor suppressor APC","volume":"14, (2)","author":"Tacchelly-Benites","year":"2018","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/j.bcp.2023.115923_b0355","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1074\/jbc.M111.323337","article-title":"Adenomatous polyposis coli (APC) regulates multiple signaling pathways by enhancing glycogen synthase kinase-3 (GSK-3) activity","volume":"287","author":"Valvezan","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0360","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molcel.2018.07.040","article-title":"Identification of ICAT as an APC Inhibitor, Revealing Wnt-Dependent Inhibition of APC-Axin Interaction","volume":"72","author":"Ji","year":"2018","journal-title":"Mol. Cell"},{"issue":"34","key":"10.1016\/j.bcp.2023.115923_b0365","doi-asserted-by":"crossref","first-page":"28552","DOI":"10.1074\/jbc.M112.387878","article-title":"Reversible modification of adenomatous polyposis coli (APC) with K63-linked polyubiquitin regulates the assembly and activity of the beta-catenin destruction complex","volume":"287","author":"Tran","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115923_b0370","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.isci.2018.07.007","article-title":"Understanding How Wnt Influences Destruction Complex Activity and beta-Catenin Dynamics","volume":"6","author":"Mukherjee","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.bcp.2023.115923_b0375","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/cells8101148","article-title":"Intracellular Signals Activated by Canonical Wnt Ligands Independent of GSK3 Inhibition and beta-Catenin Stabilization","volume":"8","author":"Garcia de Herreros","year":"2019","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.bcp.2023.115923_b0380","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1073\/pnas.1812943116","article-title":"Abnormal glycogen storage in tuberous sclerosis complex caused by impairment of mTORC1-dependent and -independent signaling pathways","volume":"116","author":"Pal","year":"2019","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bcp.2023.115923_b0385","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/mp.2013.21","article-title":"Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways","volume":"19","author":"Chakraborty","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bcp.2023.115923_b0390","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2005.06.009","article-title":"Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin","volume":"19","author":"Ding","year":"2005","journal-title":"Mol. Cell"},{"issue":"23","key":"10.1016\/j.bcp.2023.115923_b0395","doi-asserted-by":"crossref","first-page":"16989","DOI":"10.1074\/jbc.M700610200","article-title":"Resolution of the nuclear localization mechanism of glycogen synthase kinase-3","volume":"282","author":"Meares","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115923_b0400","doi-asserted-by":"crossref","first-page":"e01998","DOI":"10.7554\/eLife.01998","article-title":"Structural Basis of GSK-3 Inhibition by N-Terminal Phosphorylation and by the Wnt Receptor LRP6","volume":"3","author":"Stamos","year":"2014","journal-title":"eLife"},{"issue":"7","key":"10.1016\/j.bcp.2023.115923_b0405","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1601-183X.2010.00617.x","article-title":"A haplotype of glycogen synthase kinase 3beta is associated with early onset of unipolar major depression","volume":"9","author":"Saus","year":"2010","journal-title":"Genes Brain Behav."},{"issue":"3","key":"10.1016\/j.bcp.2023.115923_b0410","doi-asserted-by":"crossref","first-page":"e5928","DOI":"10.1097\/MD.0000000000005928","article-title":"The gender-specific association of rs334558 in GSK3beta with major depressive disorder","volume":"96","author":"Liu","year":"2017","journal-title":"Med. (Baltimore)"},{"issue":"1\u20133","key":"10.1016\/j.bcp.2023.115923_b0415","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jad.2012.08.025","article-title":"Glycogen synthase kinase 3beta gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium","volume":"147","author":"Lin","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bcp.2023.115923_b0420","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3233\/JAD-142025","article-title":"Genetic variants of GSK3\u03b2 are associated withbiomarkers for Alzheimer's disease and cognitive function","volume":"44","author":"Kettunen","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.bcp.2023.115923_b0425","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ana.20691","article-title":"GSK3B polymorphisms alter transcription and splicing in Parkinson\u2019s disease","volume":"58","author":"Kwok","year":"2005","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0430","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1468-1331.2009.02908.x","article-title":"Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3\u03b2) on the risk of Parkinson\u2019s disease","volume":"17","author":"Infante","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115923_b0435","doi-asserted-by":"crossref","first-page":"546.e1","DOI":"10.1016\/j.neurobiolaging.2009.05.007","article-title":"GSK3\u03b2 polymorphisms, MAPT H1 haplotype and Parkinson\u2019s disease in a Greek cohort","volume":"32","author":"Kalinderi","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.bcp.2023.115923_b0440","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.21687","article-title":"Glycogen synthase kinase-3\u03b2 and tau genes interact in Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"65","author":"Garc\u00eda-Gorostiaga","year":"2009","journal-title":"Ann. Neurol."},{"issue":"9533","key":"10.1016\/j.bcp.2023.115923_b0445","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2023.115923_b0450","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.7766","article-title":"Aqueous extract of Ceratonia siliqua L. leaves elicits antioxidant, anti-inflammatory, and AChE inhibiting effects in amyloid-beta42-induced cognitive deficit mice: Role of alpha7-nAChR in modulating Jak2\/PI3K\/Akt\/GSK-3beta\/beta-catenin cascade","author":"El Sayed","year":"2023","journal-title":"Phytother. Res."},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b0455","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bbrc.2003.11.014","article-title":"Divergent roles of GSK3 and CDK5 in APP processing","volume":"312","author":"Ryder","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2023.115923_b0460","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0014-5793(03)01042-1","article-title":"FRAT1 peptide decreases Abeta production in swAPP(751) cells","volume":"553","author":"Li","year":"2003","journal-title":"FEBS Lett."},{"issue":"6938","key":"10.1016\/j.bcp.2023.115923_b0465","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0470","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1007\/s12035-023-03217-x","article-title":"TREM2 Inhibits Tau Hyperphosphorylation and Neuronal Apoptosis via the PI3K\/Akt\/GSK-3beta Signaling Pathway In vivo and In vitro","volume":"60","author":"Peng","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2023.115923_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110887","article-title":"Melatonin regulates Abeta production\/clearance balance and Abeta neurotoxicity: A potential therapeutic molecule for Alzheimer's disease","volume":"132","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"22","key":"10.1016\/j.bcp.2023.115923_b0480","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1021\/bi035627j","article-title":"Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing","volume":"43","author":"Su","year":"2004","journal-title":"Biochemistry"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2023.115923_b0485","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(01)02583-6","article-title":"Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100","volume":"321","author":"Sun","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.bcp.2023.115923_b0490","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2009.05.025","article-title":"A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo","volume":"35","author":"Sereno","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.bcp.2023.115923_b0495","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2174\/156720512802455386","article-title":"Roles of glycogen synthase kinase 3 in Alzheimer's disease","volume":"9","author":"Cai","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bcp.2023.115923_b0500","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/molecules25153337","article-title":"Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer's Disease Therapy","volume":"25","author":"Zagorska","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2023.115923_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174772","article-title":"Tanshinone IIA regulates glycogen synthase kinase-3beta-related signaling pathway and ameliorates memory impairment in APP\/PS1 transgenic mice","volume":"918","author":"Peng","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115923_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113207","article-title":"New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer's disease","volume":"152","author":"Wu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2023.115923_b0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","article-title":"Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease","volume":"52","author":"Barage","year":"2015","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bcp.2023.115923_b0520","article-title":"Virtual Screening and Testing of GSK-3 Inhibitors Using Human SH-SY5Y Cells Expressing Tau Folding Reporter and Mouse Hippocampal Primary Culture under Tau Cytotoxicity","author":"Lin","year":"2022","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.bcp.2023.115923_b0525","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuroscience.2020.04.019","article-title":"G-Protein Coupled Receptors and Tau-different Roles in Alzheimer's Disease","volume":"438","author":"Chidambaram","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2023.115923_b0530","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/biomedicines10123186","article-title":"Axonal Regeneration: Underlying Molecular Mechanisms and Potential Therapeutic Targets","volume":"10","author":"Akram","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bcp.2023.115923_b0535","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainres.2018.11.033","article-title":"Nerve growth factor metabolic dysfunction contributes to sevoflurane-induced cholinergic degeneration and cognitive impairments","volume":"1707","author":"Xiong","year":"2019","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.bcp.2023.115923_b0540","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1021\/tx400138s","article-title":"Nontoxic and neuroprotective beta-naphthotacrines for Alzheimer's disease","volume":"26","author":"Esquivias-Perez","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bcp.2023.115923_b0545","doi-asserted-by":"crossref","first-page":"e0174875","DOI":"10.1371\/journal.pone.0174875","article-title":"Correction: Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice","volume":"12, (3)","author":"Mellott","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bcp.2023.115923_b0550","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1111\/jcmm.13262","article-title":"Activation of GSK-3 disrupts cholinergic homoeostasis in nucleus basalis of Meynert and frontal cortex of rats","volume":"21","author":"Wang","year":"2017","journal-title":"J. Cell Mol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0555","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s12640-022-00554-y","article-title":"Inhibition of NLRP1-Dependent Pyroptosis Prevents Glycogen Synthase Kinase-3beta Overactivation-Induced Hyperphosphorylated Tau in Rats","volume":"40","author":"Liu","year":"2022","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bcp.2023.115923_b0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173402","article-title":"alpha7nAChR activation protects against oxidative stress, neuroinflammation and central insulin resistance in ICV-STZ induced sporadic Alzheimer's disease","volume":"217","author":"Yamini","year":"2022","journal-title":"Pharmacol. Biochem. Behav"},{"issue":"2","key":"10.1016\/j.bcp.2023.115923_b0565","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3233\/JAD-220704","article-title":"The Therapeutic Effects of Seven Lycopodium Compounds on Cell Models of Alzheimer's Disease","volume":"90","author":"Guo","year":"2022","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0570","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1080\/1028415X.2020.1840035","article-title":"Neuroprotective effects of natural compounds on neurotoxin-induced oxidative stress and cell apoptosis","volume":"25","author":"Chen","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.bcp.2023.115923_b0575","first-page":"1544244","article-title":"TRPV1 Modulator Ameliorates Alzheimer-Like Amyloid-beta Neuropathology via Akt\/Gsk3beta-Mediated Nrf2 Activation in the Neuro-2a\/APP Cell Model","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.bcp.2023.115923_b0580","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1007\/s12035-017-0798-6","article-title":"Natural Dietary Supplementation of Anthocyanins via PI3K\/Akt\/Nrf2\/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer's Disease","volume":"55","author":"Ali","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2023.115923_b0585","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement (N. Y.)"},{"key":"10.1016\/j.bcp.2023.115923_b0590","first-page":"2","article-title":"Anti-Inflammatory Effect of IKK-Activated GSK-3beta Inhibitory Peptide Prevented Nigrostriatal Neurodegeneration in the Rodent Model of Parkinson's Disease","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0595","doi-asserted-by":"crossref","first-page":"8918","DOI":"10.1038\/s41598-019-45509-0","article-title":"Adiponectin improves long-term potentiation in the 5XFAD mouse brain","volume":"9","author":"Wang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2023.115923_b0600","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejmech.2019.03.009","article-title":"Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review","volume":"169","author":"Dinda","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2023.115923_b0605","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1523\/JNEUROSCI.0675-20.2020","article-title":"Evidences for Adult Hippocampal Neurogenesis in Humans","volume":"41","author":"Moreno-Jimenez","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2023.115923_b0610","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuropharm.2016.12.019","article-title":"The GSK-3-inhibitor VP2.51 produces antidepressant effects associated with adult hippocampal neurogenesis","volume":"116","author":"Perez-Domper","year":"2017","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.bcp.2023.115923_b0615","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41398-017-0013-6","article-title":"Soluble Tau has devastating effects on the structural plasticity of hippocampal granule neurons","volume":"7","author":"Bolos","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0620","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2007.01.029","article-title":"LTP inhibits LTD in the hippocampus via regulation of GSK3beta","volume":"53","author":"Peineau","year":"2007","journal-title":"Neuron"},{"issue":"29","key":"10.1016\/j.bcp.2023.115923_b0625","doi-asserted-by":"crossref","first-page":"12122","DOI":"10.1523\/JNEUROSCI.0131-13.2013","article-title":"Phosphorylation of threonine-19 of PSD-95 by GSK-3beta is required for PSD-95 mobilization and long-term depression","volume":"33","author":"Nelson","year":"2013","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.bcp.2023.115923_b0630","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1523\/JNEUROSCI.2842-14.2015","article-title":"Tau phosphorylation at serine 396 residue is required for hippocampal LTD","volume":"35","author":"Regan","year":"2015","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0635","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1038\/s41598-019-45547-8","article-title":"Tau is required for the function of extrasynaptic NMDA receptors","volume":"9","author":"Pallas-Bazarra","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0640","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1248\/bpb.b21-00693","article-title":"Riluzole Promotes Neurite Growth in Rats after Spinal Cord Injury through the GSK-3beta\/CRMP-2 Pathway","volume":"45","author":"Xu","year":"2022","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bcp.2023.115923_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106152","article-title":"Targeting neuronal calcium channels and GSK3beta for Alzheimer's disease with naturally-inspired Diels-Alder adducts","volume":"129","author":"Bisi","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0650","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1523\/JNEUROSCI.2774-16.2016","article-title":"Pharmacological Rescue of Long-Term Potentiation in Alzheimer Diseased Synapses","volume":"37","author":"Prieto","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2023.115923_b0655","doi-asserted-by":"crossref","first-page":"4209475","DOI":"10.1155\/2019\/4209475","article-title":"GSK-3beta at the Intersection of Neuronal Plasticity and Neurodegeneration","volume":"2019","author":"Jaworski","year":"2019","journal-title":"Neural Plast."},{"issue":"45","key":"10.1016\/j.bcp.2023.115923_b0660","doi-asserted-by":"crossref","first-page":"12211","DOI":"10.1523\/JNEUROSCI.3321-07.2007","article-title":"Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments","volume":"27","author":"Zhu","year":"2007","journal-title":"J. Neurosci."},{"issue":"34","key":"10.1016\/j.bcp.2023.115923_b0665","doi-asserted-by":"crossref","first-page":"26369","DOI":"10.1074\/jbc.M110.121376","article-title":"Regulation of AMPA receptor trafficking and function by glycogen synthase kinase 3","volume":"285","author":"Wei","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2023.115923_b0670","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1111\/ejn.14841","article-title":"GSK-3beta regulates the synaptic expression of NMDA receptors via phosphorylation of phosphatidylinositol 4 kinase type IIalpha","volume":"54","author":"Amici","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bcp.2023.115923_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101709","article-title":"Comparative efficacy of lithium and aducanumab for cognitive decline in patients with mild cognitive impairment or Alzheimer's disease: A systematic review and network meta-analysis","volume":"81","author":"Terao","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bcp.2023.115923_b0680","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1192\/bjp.bp.106.029868","article-title":"Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder","volume":"190","author":"Nunes","year":"2007","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0685","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1192\/bjp.2019.76","article-title":"Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial","volume":"215","author":"Forlenza","year":"2019","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0690","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1192\/bjp.bp.110.082875","article-title":"More good news about the magic ion: lithium may prevent dementia","volume":"198","author":"Young","year":"2011","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0695","first-page":"46","article-title":"Revisiting global cognitive and functional state 13 years after a clinical trial of lithium for mild cognitive impairment","volume":"45","author":"Damiano","year":"2023","journal-title":"Braz. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0700","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1192\/bjp.bp.110.080044","article-title":"Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial","volume":"198","author":"Forlenza","year":"2011","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bcp.2023.115923_b0705","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and Pathogenesis of Parkinson's Syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bcp.2023.115923_b0710","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.phrs.2015.03.010","article-title":"Glycogen synthase kinase-3 beta (GSK-3beta) signaling: Implications for Parkinson's disease","volume":"97","author":"Golpich","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2023.115923_b0715","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijbiomac.2021.03.040","article-title":"Loss of GSK-3beta mediated phosphorylation in HtrA2 contributes to uncontrolled cell death with Parkinsonian phenotype","volume":"180","author":"Bose","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.bcp.2023.115923_b0720","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.4014\/jmb.2205.05032","article-title":"Agathobaculum butyriciproducens Shows Neuroprotective Effects in a 6-OHDA-Induced Mouse Model of Parkinson's Disease","volume":"32","author":"Lee","year":"2022","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.bcp.2023.115923_b0725","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fnmol.2020.00081","article-title":"GSK-3beta Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib","volume":"13","author":"Li","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0730","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/cdd.2014.179","article-title":"GSK-3beta dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and alpha-synuclein","volume":"22","author":"Credle","year":"2015","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.bcp.2023.115923_b0735","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/cn300182g","article-title":"Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease","volume":"4","author":"Morales-Garcia","year":"2013","journal-title":"ACS Chem. Nerosci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0740","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-019-0329-1","article-title":"Alpha-synuclein structure and Parkinson's disease - lessons and emerging principles","volume":"14","author":"Meade","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.bcp.2023.115923_b0745","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.toxlet.2014.11.029","article-title":"The molecular mechanism of rotenone-induced alpha-synuclein aggregation: emphasizing the role of the calcium\/GSK3beta pathway","volume":"233","author":"Yuan","year":"2015","journal-title":"Toxicol. Lett."},{"issue":"9","key":"10.1016\/j.bcp.2023.115923_b0750","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"12","key":"10.1016\/j.bcp.2023.115923_b0755","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1007\/s12035-021-02558-9","article-title":"alpha-Synuclein Induces the GSK-3-Mediated Phosphorylation and Degradation of NURR1 and Loss of Dopaminergic Hallmarks","volume":"58","author":"Garcia-Yague","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b0760","doi-asserted-by":"crossref","first-page":"e94259","DOI":"10.1371\/journal.pone.0094259","article-title":"Extracellular alpha-synuclein leads to microtubule destabilization via GSK-3beta-dependent Tau phosphorylation in PC12 cells","volume":"9","author":"Gassowska","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2023.115923_b0765","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ana.20764","article-title":"Tau kinases and Parkinson's disease: guilt by association?","volume":"58","author":"Dickson","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2023.115923_b0770","article-title":"The PI3K-AKT pathway: A plausible therapeutic target in Parkinson's disease","volume":"104846","author":"Goyal","year":"2022","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bcp.2023.115923_b0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2022.104846","article-title":"The PI3K-AKT pathway: A plausible therapeutic target in Parkinson's disease","volume":"129","author":"Goyal","year":"2023","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bcp.2023.115923_b0780","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/ijms24065941","article-title":"Altered Intracellular Signaling Associated with Dopamine D2 Receptor in the Prefrontal Cortex in Wistar Kyoto Rats","volume":"24","author":"Korlatowicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0785","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1038\/s41598-018-20342-z","article-title":"Involvement of PKA\/DARPP-32\/PP1alpha and beta- arrestin\/Akt\/GSK-3beta Signaling in Cadmium-Induced DA-D2 Receptor-Mediated Motor Dysfunctions: Protective Role of Quercetin","volume":"8","author":"Gupta","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0790","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2007.11.041","article-title":"A beta-arrestin 2 signaling complex mediates lithium action on behavior","volume":"132","author":"Beaulieu","year":"2008","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0795","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biopsych.2006.03.020","article-title":"Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals","volume":"61","author":"Salahpour","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"14","key":"10.1016\/j.bcp.2023.115923_b0800","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b0805","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1021\/acschemneuro.0c00722","article-title":"Targeting ROS-Dependent AKT\/GSK-3beta\/NF-kappaB and DJ-1\/Nrf2 Pathways by Dapagliflozin Attenuates Neuronal Injury and Motor Dysfunction in Rotenone-Induced Parkinson's Disease Rat Model","volume":"12","author":"Arab","year":"2021","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.bcp.2023.115923_b0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119704","article-title":"Lipid-based nanodelivery approaches for dopamine-replacement therapies in Parkinson's disease: From preclinical to translational studies","volume":"232","author":"Karthivashan","year":"2020","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.bcp.2023.115923_b0815","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/1440-1681.13305","article-title":"Inhibition of GSK3beta protects against collagen type II-induced arthritis associated with a decrease in synovial leukocyte infiltration and inhibition of endoplasmic reticulum stress and autophagy biomarkers","volume":"47","author":"Alzamil","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bcp.2023.115923_b0820","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1242\/jcs.248534","article-title":"Endoplasmic reticulum-mitochondria signaling in neurons and neurodegenerative diseases","volume":"135","author":"Markovinovic","year":"2022","journal-title":"J. Cell Sci."},{"issue":"10","key":"10.1016\/j.bcp.2023.115923_b0825","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1111\/jcmm.13706","article-title":"Bradykinin-mediated Ca(2+) signalling regulates cell growth and mobility in human cardiac c-Kit(+) progenitor cells","volume":"22","author":"Li","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2023.115923_b0830","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","article-title":"Endoplasmic reticulum stress signals in the tumour and its microenvironment","volume":"21","author":"Chen","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2023.115923_b0835","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1039\/c9mt00264b","article-title":"Zn(2+) and mPTP mediate resveratrol-induced myocardial protection from endoplasmic reticulum stress","volume":"12","author":"He","year":"2020","journal-title":"Metallomics : Integrated Biometal Sci."},{"issue":"11","key":"10.1016\/j.bcp.2023.115923_b0840","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/MCB.01510-14","article-title":"Serum- and Glucocorticoid-Inducible Kinase 1 Confers Protection in Cell-Based and in In Vivo Neurotoxin Models via the c-Jun N-Terminal Kinase Signaling Pathway","volume":"35","author":"Iqbal","year":"2015","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0845","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1468-1331.2009.02908.x","article-title":"Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3beta) on the risk of Parkinson's disease","volume":"17","author":"Infante","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bcp.2023.115923_b0850","doi-asserted-by":"crossref","first-page":"(8)","DOI":"10.3390\/molecules24081583","article-title":"Oxidative Stress: A Key Modulator in Neurodegenerative Diseases","volume":"24","author":"Singh","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2023.115923_b0855","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijms21249661","article-title":"Mitophagy and the Brain","volume":"21","author":"Swerdlow","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b0860","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1159\/000485580","article-title":"The Key Roles of GSK-3beta in Regulating Mitochondrial Activity","volume":"44","author":"Yang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"7","key":"10.1016\/j.bcp.2023.115923_b0865","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.celrep.2018.04.045","article-title":"GSK3beta Regulates Brain Energy Metabolism","volume":"23","author":"Martin","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0870","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1038\/s41467-021-25651-y","article-title":"Small-molecule suppression of calpastatin degradation reduces neuropathology in models of Huntington's disease","volume":"12","author":"Hu","year":"2021","journal-title":"Nat. Commun."},{"issue":"42","key":"10.1016\/j.bcp.2023.115923_b0875","doi-asserted-by":"crossref","first-page":"29285","DOI":"10.1074\/jbc.M114.563924","article-title":"Translocation of glycogen synthase kinase-3beta (GSK-3beta), a trigger of permeability transition, is kinase activity-dependent and mediated by interaction with voltage-dependent anion channel 2 (VDAC2)","volume":"289","author":"Tanno","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.bcp.2023.115923_b0880","doi-asserted-by":"crossref","first-page":"9993","DOI":"10.1523\/JNEUROSCI.2057-04.2004","article-title":"Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis","volume":"24","author":"Linseman","year":"2004","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b0885","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41419-018-0424-1","article-title":"Mitochondria-associated membranes (MAMs) and pathologies","volume":"9","author":"Pinton","year":"2018","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bcp.2023.115923_b0890","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.15252\/embr.201541726","article-title":"ALS\/FTD-associated FUS activates GSK-3beta to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations","volume":"17","author":"Stoica","year":"2016","journal-title":"EMBO Rep."},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b0895","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0900","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41556-018-0205-1","article-title":"mTOR as a central hub of nutrient signalling and cell growth","volume":"21","author":"Kim","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"6036","key":"10.1016\/j.bcp.2023.115923_b0905","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bcp.2023.115923_b0910","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b0915","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009357","article-title":"The role of autophagy in Parkinson's disease","volume":"2","author":"Lynch-Day","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"9","key":"10.1016\/j.bcp.2023.115923_b0920","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41580-018-0033-y","article-title":"Autophagy as a promoter of longevity: insights from model organisms","volume":"19","author":"Hansen","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115923_b0925","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","article-title":"Mechanism and medical implications of mammalian autophagy","volume":"19","author":"Dikic","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115923_b0930","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","article-title":"TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth","volume":"126","author":"Inoki","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2023.115923_b0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109597","article-title":"GSK-3-TSC axis governs lysosomal acidification through autophagy and endocytic pathways","volume":"71","author":"Avrahami","year":"2020","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.bcp.2023.115923_b0940","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.molcel.2013.03.022","article-title":"Inhibition of AMPK catabolic action by GSK3","volume":"50","author":"Suzuki","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2023.115923_b0945","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fphar.2019.00320","article-title":"6-Bromoindirubin-3'-Oxime (6BIO) Suppresses the mTOR Pathway, Promotes Autophagy, and Exerts Anti-aging Effects in Rodent Liver","volume":"10","author":"Guo","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2023.115923_b0950","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.neuron.2023.02.028","article-title":"Lost in local translation: TDP-43 and FUS in axonal\/neuromuscular junction maintenance and dysregulation in amyotrophic lateral sclerosis","volume":"111","author":"Piol","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2023.115923_b0955","doi-asserted-by":"crossref","DOI":"10.1038\/s41576-023-00592-y","article-title":"Amyotrophic lateral sclerosis: translating genetic discoveries into therapies","author":"Akcimen","year":"2023","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.bcp.2023.115923_b0960","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0021-9258(17)49926-1","article-title":"Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules","volume":"295","author":"Hans","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115923_b0965","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/brainsci10100675","article-title":"Recent Advances on the Role of GSK3beta in the Pathogenesis of Amyotrophic Lateral Sclerosis","volume":"10","author":"Choi","year":"2020","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b0970","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","article-title":"TDP-43 Pathology in Alzheimer's Disease","volume":"16","author":"Meneses","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bcp.2023.115923_b0975","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/ijms22168975","article-title":"Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3beta as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis","volume":"22","author":"Martinez-Gonzalez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2023.115923_b0980","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1111\/ejn.14762","article-title":"Cytoplasmic localization of amyotrophic lateral sclerosis-related TDP-43 proteins modulates stress granule formation","volume":"52","author":"Besnard-Guerin","year":"2020","journal-title":"Eur. J. Neurosci."},{"issue":"10","key":"10.1016\/j.bcp.2023.115923_b0985","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bcp.2023.115923_b0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104639","article-title":"Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum","volume":"134","author":"Baradaran-Heravi","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.bcp.2023.115923_b0995","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1021\/acschemneuro.9b00026","article-title":"TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral Sclerosis","volume":"10","author":"Palomo","year":"2019","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.bcp.2023.115923_b1000","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.14327","article-title":"Pathomechanisms of TDP-43 in neurodegeneration","author":"Gao","year":"2018","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.bcp.2023.115923_b1005","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.4130","article-title":"The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity","volume":"22","author":"Wang","year":"2016","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bcp.2023.115923_b1010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2023.115923_b1015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neuroscience.2021.10.023","article-title":"Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology","volume":"518","author":"Andres-Benito","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2023.115923_b1020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.brainres.2007.12.031","article-title":"Upregulation of GSK3beta expression in frontal and temporal cortex in ALS with cognitive impairment (ALSci)","volume":"1196","author":"Yang","year":"2008","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.bcp.2023.115923_b1025","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.stem.2013.04.003","article-title":"A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS","volume":"12","author":"Yang","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"16","key":"10.1016\/j.bcp.2023.115923_b1030","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.cub.2015.06.045","article-title":"Age-Dependent TDP-43-Mediated Motor Neuron Degeneration Requires GSK3, hat-trick, and xmas-2","volume":"25","author":"Sreedharan","year":"2015","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bcp.2023.115923_b1035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijms222111853","article-title":"Regulation of Endoplasmic Reticulum-Mitochondria Tethering and Ca(2+) Fluxes by TDP-43 via GSK3beta","volume":"22","author":"Peggion","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2023.115923_b1040","article-title":"When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease","volume":"22","author":"D'Mello","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b1045","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12035-015-9662-8","article-title":"Huntington's Disease: Relationship Between Phenotype and Genotype","volume":"54","author":"Sun","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2023.115923_b1050","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101358","article-title":"Systemic manifestation and contribution of peripheral tissues to Huntington's disease pathogenesis","volume":"69","author":"Chuang","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bcp.2023.115923_b1055","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington Disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"8","key":"10.1016\/j.bcp.2023.115923_b1060","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn3068","article-title":"Fighting neurodegeneration with rapamycin: mechanistic insights","volume":"12","author":"Bove","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bcp.2023.115923_b1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105336","article-title":"Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease","volume":"154","author":"Rippin","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b1070","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.104","article-title":"GSK-3beta-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactions","volume":"7","author":"L'Episcopo","year":"2016","journal-title":"Cell Death Dis."},{"issue":"s1","key":"10.1016\/j.bcp.2023.115923_b1075","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.3233\/JAD-190851","article-title":"Role of Phosphorylated Tau and Glucose Synthase Kinase 3 Beta in Huntington's Disease Progression","volume":"72","author":"Sawant","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"17","key":"10.1016\/j.bcp.2023.115923_b1080","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1093\/hmg\/ddv224","article-title":"Decreased glycogen synthase kinase-3 levels and activity contribute to Huntington's disease","volume":"24","author":"Fernandez-Nogales","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.bcp.2023.115923_b1085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.nbd.2012.06.026","article-title":"NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease","volume":"48","author":"Pouladi","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b1090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s004010050436","article-title":"Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease","volume":"91","author":"Buee Scherrer","year":"1996","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b1095","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/jnc.13416","article-title":"Remarkable impairment of Wnt\/beta-catenin signaling in the brains of the mice infected with scrapie agents","volume":"136","author":"Sun","year":"2016","journal-title":"J. Neurochem."},{"issue":"20","key":"10.1016\/j.bcp.2023.115923_b1100","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1021\/acschemneuro.1c00240","article-title":"Accumulation of Prion and Abnormal Prion Protein Induces Hyperphosphorylation of alpha-Synuclein in the Brain Tissues from Prion Diseases and in the Cultured Cells","volume":"12","author":"Chen","year":"2021","journal-title":"ACS Chem. Nerosci."},{"issue":"7","key":"10.1016\/j.bcp.2023.115923_b1105","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1111\/jcmm.13626","article-title":"Endoplasmic reticulum stress induces spatial memory deficits by activating GSK-3","volume":"22","author":"Lin","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2023.115923_b1110","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105130","article-title":"TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia","volume":"146","author":"Montalbano","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.bcp.2023.115923_b1115","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/brain\/awab099","article-title":"Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease","volume":"144","author":"Spina","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b1120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jmb.2019.06.031","article-title":"Quality Control in Neurons: Mitophagy and Other Selective Autophagy Mechanisms","volume":"432","author":"Evans","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2023.115923_b1125","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejmech.2016.09.058","article-title":"Natural and synthetic bioactive inhibitors of glycogen synthase kinase","volume":"125","author":"Khan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bcp.2023.115923_b1130","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2174\/1389450122666210118150313","article-title":"Anti-inflammatory Potential of GSK-3 Inhibitors","volume":"22","author":"Kandar","year":"2021","journal-title":"Curr. Drug Targets"},{"issue":"2","key":"10.1016\/j.bcp.2023.115923_b1135","first-page":"315","article-title":"Clinically relevant GSK-3beta inhibitor 9-ING-41 is active as a single agent and in combination with other antitumor therapies in human renal cancer","volume":"45","author":"Anraku","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"9","key":"10.1016\/j.bcp.2023.115923_b1140","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1021\/jm300309a","article-title":"Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3alpha","volume":"55","author":"Lo Monte","year":"2012","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.bcp.2023.115923_b1145","doi-asserted-by":"crossref","first-page":"8907","DOI":"10.1021\/acs.jmedchem.5b01200","article-title":"Evaluation of Improved Glycogen Synthase Kinase-3alpha Inhibitors in Models of Acute Myeloid Leukemia","volume":"58","author":"Neumann","year":"2015","journal-title":"J. Med. Chem."},{"issue":"41","key":"10.1016\/j.bcp.2023.115923_b1150","doi-asserted-by":"crossref","first-page":"26551","DOI":"10.1021\/acsomega.0c03302","article-title":"Machine Learning for Discovery of GSK3beta Inhibitors","volume":"5","author":"Vignaux","year":"2020","journal-title":"ACS Omega"},{"issue":"11","key":"10.1016\/j.bcp.2023.115923_b1155","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/cn300110c","article-title":"Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo","volume":"3","author":"Morales-Garcia","year":"2012","journal-title":"ACS Chem. Nerosci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115923_b1160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer's disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.bcp.2023.115923_b1165","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mds.25824","article-title":"A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy","volume":"29","author":"Tolosa","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bcp.2023.115923_b1170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pediatrneurol.2020.08.001","article-title":"A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1)","volume":"112","author":"Horrigan","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bcp.2023.115923_b1175","doi-asserted-by":"crossref","first-page":"1028963","DOI":"10.3389\/fnmol.2022.1028963","article-title":"Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity","volume":"15","author":"Chatterjee","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.bcp.2023.115923_b1180","doi-asserted-by":"crossref","first-page":"e91782","DOI":"10.1172\/jci.insight.91782","article-title":"Intranasal siRNA administration reveals IGF2 deficiency contributes to impaired cognition in Fragile X syndrome mice","volume":"2","author":"Pardo","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.bcp.2023.115923_b1185","doi-asserted-by":"crossref","unstructured":"Rippin, I.; Khazanov, N.; Shirley Ben, J.; Kudinov, T.; Berent, E.; Arciniegas Ruiz, S. M.; Marciano, D.; Levy, L.; Gruzman, A.; Senderowitz, H.; Eldar-Finkelman, H., Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site. Int J Mol Sci 2020, 21, (22).","DOI":"10.3390\/ijms21228709"},{"key":"10.1016\/j.bcp.2023.115923_b1190","doi-asserted-by":"crossref","first-page":"(544)","DOI":"10.1126\/scitranslmed.aam8572","article-title":"Selective inhibition of glycogen synthase kinase 3alpha corrects pathophysiology in a mouse model of fragile X syndrome","volume":"12","author":"McCamphill","year":"2020","journal-title":"Sci. Transl. Med."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223005166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223005166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T01:10:10Z","timestamp":1731028210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223005166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":238,"alternative-id":["S0006295223005166"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115923","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115923"}}